Notice of IMC Shareholder Presentation
Company to present details of Superdrug commercial agreement for AxisBiotix food supplements on 3 July 2025.
Select text to share a quote on X · sign in to keep highlights & notes in your SBTX notes
27 June 2025 - SkinBioTherapeutics plc (AIM: SBTX), a life science group focused on skin health, will be providing a short presentation to shareholders on Thursday 3 July 2025 at 11am BST about the recently signed exclusive UK commercial agreement with Superdrug Stores plc, one of the UK's leading beauty and health retailers, related to its AxisBiotix™ food supplements to alleviate the symptoms of inflammatory skin conditions.
The presentation will be open to all existing and potential SkinBioTherapeutics shareholders. Investors who already follow SkinBioTherapeutics on the Investor Meet Company (IMC) platform will be invited automatically. Investors can sign up to Investor Meet Company for free Here.
The Company intends to hold an IMC shareholder presentation at a later date for a pre-close trading update.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.